GALE.ZU Galenica AG
Performance
0% Past Week
Market Cap
3.74B
Day’s Range
52W Range
Volume (3M)
100.21K
Price-Earnings Ratio
21.81
Revenue
4.01B
About Galenica AG
Galenica AG dates back to 1927 and is based in Switzerland. The company provides pre-wholesale and wholesale distribution services in the Swiss healthcare market. These include services such as marketing, distribution and supply chain management of OTC (over the counter), parapharmaceutical and health and beauty products.
Galenica operates the largest network of pharmacies in Switzerland and offers a wide range of owned brands and products, exclusive brands and products from business partners, and on-site health services and tests. The company has nearly 500 own, joint venture and independent partner pharmacies.
In 2019, it was announced that the Galenica Group will acquire a majority stake in the Bichsel Group, a specialised Swiss company with a strong focus on the manufacture of individual medicines and medical devices as well as home care services in the field of home dialysis and home nutrition.
Financial results for the first half of fiscal 2019 include an increase of 2.2% in net sales, year-over-year, reaching CHF 1,600.4 million. Learn more about this instrument and buy GALE.ZU stocks.
Show More5.7K
Employees
CH
HQ
1927
Founded
Marc Werner
CEO
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
58
High
Industry
Avg. 57
56
Environment
65
Social
54
Governance
People Also Bought
- ALC.ZU Alcon Inc. -0.38%
- EMSN.ZU Ems-Chemie Holding AG 0.97%
- FHZN.ZU Flughafen Zurich AG 1.41%
- HELN.ZU Helvetia Holding AG 1.38%
- VACN.ZU VAT Group Ltd 0.45%
75.39